Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 14 | 2024 | 891 | 2.990 |
Why?
|
| Death, Sudden | 4 | 2018 | 48 | 1.630 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2023 | 91 | 1.480 |
Why?
|
| Epilepsies, Partial | 6 | 2020 | 95 | 1.090 |
Why?
|
| Brain Stem | 2 | 2020 | 119 | 0.710 |
Why?
|
| Epilepsy, Generalized | 2 | 2020 | 65 | 0.710 |
Why?
|
| Spasms, Infantile | 1 | 2022 | 175 | 0.670 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 8 | 0.630 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 201 | 0.600 |
Why?
|
| RNA Splicing | 1 | 2020 | 247 | 0.580 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 49 | 0.570 |
Why?
|
| Genetic Variation | 2 | 2023 | 1580 | 0.560 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 613 | 0.480 |
Why?
|
| Sudden Infant Death | 1 | 2016 | 36 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 3358 | 0.470 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 608 | 0.470 |
Why?
|
| Heart Rate | 1 | 2018 | 584 | 0.470 |
Why?
|
| Cognition Disorders | 1 | 2018 | 571 | 0.440 |
Why?
|
| Penetrance | 1 | 2014 | 113 | 0.440 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 554 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1134 | 0.420 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 274 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2018 | 479 | 0.390 |
Why?
|
| Heterozygote | 4 | 2020 | 715 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3852 | 0.330 |
Why?
|
| Neurons | 2 | 2020 | 2015 | 0.330 |
Why?
|
| Brain | 2 | 2024 | 3194 | 0.290 |
Why?
|
| Electric Stimulation Therapy | 2 | 2020 | 84 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 755 | 0.240 |
Why?
|
| Humans | 25 | 2024 | 132081 | 0.240 |
Why?
|
| Intellectual Disability | 2 | 2020 | 1094 | 0.240 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2020 | 235 | 0.240 |
Why?
|
| Seizures | 2 | 2020 | 895 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2006 | 372 | 0.210 |
Why?
|
| Empiricism | 1 | 2023 | 1 | 0.210 |
Why?
|
| Electrodes, Implanted | 3 | 2019 | 177 | 0.210 |
Why?
|
| Electrocorticography | 1 | 2024 | 74 | 0.200 |
Why?
|
| Chromosome Deletion | 1 | 2006 | 656 | 0.190 |
Why?
|
| Temporal Lobe | 1 | 2023 | 118 | 0.190 |
Why?
|
| Glycosylation | 1 | 2022 | 126 | 0.190 |
Why?
|
| Genetic Testing | 2 | 2023 | 1098 | 0.190 |
Why?
|
| Electroencephalography | 4 | 2024 | 908 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2020 | 14719 | 0.180 |
Why?
|
| Hippocampus | 3 | 2023 | 820 | 0.170 |
Why?
|
| Abnormalities, Multiple | 2 | 2007 | 982 | 0.170 |
Why?
|
| Adult | 11 | 2020 | 31558 | 0.170 |
Why?
|
| Deep Brain Stimulation | 2 | 2017 | 432 | 0.170 |
Why?
|
| Mutation | 1 | 2014 | 6250 | 0.170 |
Why?
|
| Male | 14 | 2020 | 64952 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 20 | 0.170 |
Why?
|
| Axon Guidance | 1 | 2020 | 4 | 0.160 |
Why?
|
| Young Adult | 7 | 2020 | 9938 | 0.160 |
Why?
|
| Infant | 4 | 2018 | 13037 | 0.160 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 2 | 2018 | 15 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 46 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 199 | 0.150 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 25 | 0.150 |
Why?
|
| Language Development Disorders | 1 | 2020 | 179 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 13 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 5407 | 0.140 |
Why?
|
| Adolescent | 8 | 2020 | 20530 | 0.140 |
Why?
|
| Female | 14 | 2020 | 70699 | 0.140 |
Why?
|
| Atrophy | 1 | 2018 | 251 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2020 | 679 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2020 | 364 | 0.140 |
Why?
|
| Zebrafish | 1 | 2020 | 421 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3045 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 308 | 0.120 |
Why?
|
| Neocortex | 1 | 2017 | 74 | 0.120 |
Why?
|
| ERG1 Potassium Channel | 1 | 2016 | 4 | 0.120 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2016 | 9 | 0.120 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2016 | 11 | 0.120 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 13 | 0.120 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2016 | 42 | 0.120 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2016 | 40 | 0.120 |
Why?
|
| Base Sequence | 1 | 2020 | 2899 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 64 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2016 | 161 | 0.110 |
Why?
|
| Brain Waves | 1 | 2015 | 47 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2015 | 195 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 484 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 652 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 2013 | 118 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2013 | 63 | 0.100 |
Why?
|
| Child | 4 | 2018 | 25758 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 178 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 2159 | 0.080 |
Why?
|
| Ion Channels | 1 | 2011 | 206 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2011 | 200 | 0.080 |
Why?
|
| Ethics, Medical | 1 | 2011 | 401 | 0.070 |
Why?
|
| Brain Mapping | 2 | 2024 | 406 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3984 | 0.070 |
Why?
|
| Middle Aged | 6 | 2020 | 28980 | 0.070 |
Why?
|
| Animals | 4 | 2020 | 34845 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 1479 | 0.060 |
Why?
|
| Stroke | 1 | 2015 | 1082 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 4687 | 0.060 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 182 | 0.060 |
Why?
|
| Mice | 3 | 2020 | 18502 | 0.060 |
Why?
|
| Mutation, Missense | 3 | 2019 | 937 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2011 | 551 | 0.060 |
Why?
|
| Video Recording | 1 | 2006 | 204 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2442 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2007 | 794 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1883 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 712 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1652 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 1096 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2018 | 17367 | 0.050 |
Why?
|
| Benchmarking | 1 | 2024 | 137 | 0.050 |
Why?
|
| Syndrome | 1 | 2006 | 1174 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2850 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 574 | 0.040 |
Why?
|
| Risk Factors | 1 | 2015 | 10936 | 0.040 |
Why?
|
| Societies | 1 | 2020 | 27 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 361 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 81 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 42 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 239 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 535 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2020 | 157 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2020 | 210 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 156 | 0.040 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 187 | 0.030 |
Why?
|
| Suicide | 1 | 2020 | 203 | 0.030 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 3 | 0.030 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2017 | 14 | 0.030 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2017 | 16 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 6557 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2020 | 481 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 217 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 294 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 1122 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 1249 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1685 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 821 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 751 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 21456 | 0.030 |
Why?
|
| Quality Control | 1 | 2012 | 123 | 0.020 |
Why?
|
| Consent Forms | 1 | 2011 | 22 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2020 | 13015 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2012 | 151 | 0.020 |
Why?
|
| Genetic Privacy | 1 | 2011 | 43 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 242 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 102 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1653 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Informed Consent | 1 | 2011 | 346 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 698 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2011 | 387 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2680 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2007 | 253 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2007 | 283 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1331 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6443 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1718 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 5169 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3727 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 7125 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3868 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 4758 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 4539 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2953 | 0.010 |
Why?
|